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What do we learn from this article? 
TSH levels may have a role in maintaining Cholesterol levels during pregnancy.  
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ABSTRACT 
Introduction: Thyroid hormones have significant functions in embryogenesis and fetal 
development. Evidence suggests that thyroid stimulating hormone (TSH) may exert extra-
thyroidal effects and modify the profile of blood lipids. 
Aim: To determine the association between maternal blood lipid profile and thyroid 
stimulating hormone in second and third trimester of pregnancy. 
Methods & Materials: The present study was carried out at MGM Hospital, Navi Mumbai, 
India. 200 antenatal cases from October, 2012 to October 2014 were enrolled after taking 
an informed consent. The blood samples for Thyroid stimulating hormone and lipid profile 
were taken at 16th and 32nd weeks. 
Results: The mean TSH level in second trimester was 1.53 mIU/L, with a standard deviation 
of 1.147 mIU/L. In third trimester, the mean TSH level was increased to 2.60 mIU/L with a 
standard deviation of 0.836mIU/L. The t-stat value was found to be -10.649 (p < 0.001). In 
third trimester, TSH was negatively correlated with Cholesterol (r= -0.214, p < 0.01) and 
VLDL (r= -0.148, p < 0.05). With increase in TSH level, cholesterol level will decrease. 
Conclusion: TSH levels rises according to the gestational age, being higher in third 
trimester as compared to second trimester. There is a significant negative correlation 
between TSH levels and cholesterol & VLDL in third trimester of the pregnancy. Hence, 
TSH levels should be looked for, especially in third trimester, in order to keep the thyroid 
related problems in check. 
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Introduction 
Thyroid hormones have important functions in embryogenesis 
and fetal development [1,2]. It is widely known that thyroid 
function undergoes many significant changes during pregnancy 
[3-5].  
The size of the thyroid gland remains however normal during 
pregnancy. Thus, the presence of goitre should always be 
investigated. A meta-analysis of various available studies of 
thyroid gland’s size and function in pregnancy found out that 
thyroid size, when estimated by inspection and palpation or 
measured by ultrasonography (USG), increased only in iodine 
deficiency, and the increase in glandular size remained within 
the normal range [6]. 
Controlled hyper-stimulation of the ovaries with exogenous 
gonadotropins (for in vitro fertilization) resulted in a rise of 
serum Thyroid Binding Globulin (TBG), Thyroxine (T4), and 
triiodothyronine (T3) concentrations while there was a fall in 
serum free T4 concentration, and a small rise in serum TSH 
concentrations (usually within the normal range) [7]. 
The serum TBG concentration usually rises twofold in 
pregnancy because of estrogen which both increases TBG 
production and sialylation; the latter generally reduces the 
clearance of TBG [8.9]. TBG excess leads to an increment in 
both serum T4 and T3 concentrations, but not the serum free 
T4 and T3 concentrations. 
Thus, total T4 and T3 concentrations generally, rise during the 
first half of pregnancy, however plateauing at approximately 20 
weeks of gestation is seen, and then a new steady state is 
reached and the overall production rate of thyroid hormones 
returns to pre-pregnancy rates. Thus, TBG excess leads to an 
overall increase in both serum total T4 and T3 concentrations. 
Also, TSH levels are usually suppressed due to very high levels 
of Human chorionic gonadotropin (hCG) during the first half of 
the pregnancy, especially the first trimester. hCG, a 
glycoprotein hormone which secreted by placenta, shares a 
common alpha subunit with TSH, hence can act as a weak TSH-
receptor agonist [10]. hCG has a mild stimulatory effect on the 
thyroid gland, and can cause a transient “physiological” 
elevation of thyroxine (FT4) and free triiodothyronine (FT3) 
[11]. TSH levels measurement at this time therefore, may not 
provide a good indicator of thyroid function. Later phases of 
gestation, it has been suggested, could be more reflective of 
maternal thyroid status [12].  
Thyroid dysfunction without any primary thyroid disease may 
result in various qualitative or quantitative changes of 
triglycerides, phospholipids, cholesterol, and other lipoproteins 
[13]. Dyslipidemia, a consequence of thyroid dysfunction, 
generally increases the risk for cardiovascular disease [14-16]. 
Previous studies have shown that thyroid stimulating hormone 
(TSH), free thyroxine (FT4) and free triiodothyronine (FT3) are 
significantly associated with lipid profile in the euthyroid 
population, regardless of gender [17,18].  
The influence of TSH on lipid profile has been assumed to be 
mediated indirectly, through its effect on thyroid hormones. 
However, additional evidence suggests that this association is 
partially contributed by the direct extra-thyroidal effect of TSH 
on lipid profile [19,20]. Normal pregnancy is associated with 
predicted changes in lipid metabolism and elevation in lipid 
concentration as gestation progresses [21]. However, these 
changes are considered to be generally non-atherogenic, and 
fall sharply to pre-pregnancy levels following delivery [22,23].  
Understanding the physiology of thyroid stimulating hormone 
in normal pregnancy have highlighted the importance of the 
consequences of abnormal function on obstetric outcome and 
fetal well-being. As to how modification in thyroid stimulating 
hormone modulates changes in lipid profile is yet to be 
ascertained in an Indian population. The present study is the 
continuation of the previous study [24] and it aims to 
determine the association between thyroid stimulating 
hormone and lipid profile in Indian pregnant women. 
Aim  
To evaluate the association between thyroid stimulating 
hormone and lipid profile in Indian normotensive pregnant 
women. 
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Material, Methods, Ethics, Statistical Analysis, 
Inclusion and Exclusion Criteria 
The present study is a continuation of our previous study and 
the material, methods, ethics, inclusion and exclusion criteria 
could be obtained from our previous study [5].  
In brief, the present study was conducted at MGM Hospital, 
Navi Mumbai, India. 200 antenatal cases from October, 2012 to 
October 2014 were enrolled after taking an informed consent. 
Out of the 200 subjects, 10 developed GHTN in late third 
trimester which was detected after 32nd week during follow-
up which were also included. The venous blood sample was 
collected from all the patients for measurement of lipid and 
thyroid profile in the 16th week and 32nd week of gestation for 
analysis. 
All pregnant women with a singleton pregnancy with a 
gestational age of 13-28 weeks, irrespective of parity and 
gravida were included. Pregnant women in whom hypertension 
(HTN) was detected before 14 weeks and those with diseases 
or complications like chronic HTN, Obstetric and Foetal 
Complications (Hydrops foetalis, congenital foetal anomalies), 
Diabetes, Renal Disorders and Thyroid Disorders were 
excluded. 
Statistical analyses were performed using Statistical Package 
for Social Sciences (SPSS) version 20. All reported P values are 
two-tailed, and confidence intervals were calculated at the 95% 
level. The data was presented using frequencies, percentages, 
descriptive statistics followed by charts and graphs. Level of 
significance was set at 5%. All p-values less than 0.05 were 
treated as significant. 
Results 
The mean TSH level in second trimester was 1.53 mIU/L, with a 
standard deviation of 1.147 mIU/L. In third trimester, the mean 
TSH level was increased to 2.60 mIU/L with a standard 
deviation of 0.836mIU/L. The t-stat value was found to be -
10.649 (p < 0.001) (Table 1 and Figure 1). 
 
 
 
 
N Mea
n 
SD SE
M 
T Df Sig.  
2nd 
Trime
ster 
200 1.53 1.14
7 
0.08
1 
-
10.649 
398 < 
0.001** 
3rd 
Trime
ster 
200 2.60 0.83
6 
0.05
9 
Table 1. Comparison of TSH {mIU/L) in 2nd & 3rd Trimesters 
 
 
Figure 1.TSH levels in pregnancy 
The mean Triglycerides, Cholesterol, High density lipoproteins, 
low density lipoproteins, very low density lipoproteins and TSH 
are depicted in table 2. 
 
Trimester Second  
Trimester 
Third Trimester 
Serum Cholesterol 
{mg/dl} 
214.595 ± 18.163 242.645± 20.437 
Serum Triglycerides 
{mg/dl} 
188.68 ± 20.874 216.78± 20.096 
HDL-CHOLESTEROL 
{mg/dl} 
49.125 ± 6.147 43.065± 4.364 
LDL-CHOLESTEROL 
{mg/dl} 
92.410 ±18.938 137.815± 13.451 
VLDL-CHOLESTEROL 
{mg/dl} 
28.215 ± 7.664 36.27± 6.714 
TSH Level {mIU/L} 1.528 ± 1.147 2.597± 0.836 
Table 2.Mean Values [24] 
 
During Second trimester, there is significant positive 
correlation between VLDL and HDL (r=0.158, p < 0.05). 
However, there was no significance correlation between TSH 
levels and lipid profile (Table 3). 
TSH was negatively correlated with Cholesterol (r= -0.214, p < 
0.01) and VLDL (r= -0.148, p < 0.05). This indicates that the TSH 
and Cholesterol, VLDL are directly associated. With increase in 
TSH level, cholesterol levels decreases. However, they are still 
within normal range (Table 4). 
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  TSH  Cholesterol  Triglycerides HDL LDL VLDL 
TSH              
Cholesterol  -0.017           
Triglycerides -0.130 0.061         
HDL -0.030 0.021 0.068       
LDL 0.052 -0.088 -0.002 0.010     
VLDL -0.059 -0.081 0.035 .158* 0.010   
Table 3. Correlations between TSH & Lipid Profile parameters in 2nd Trimester (** Correlation is 
significant at the 0.01 level, * Correlation is significant at the 0.05 level) 
 TSH Cholesterol Triglycerides HDL LDL VLDL 
TSH              
Cholesterol  -.214**           
Triglycerides .089 .065         
HDL -.007 .080 .160*       
LDL .096 .126 -.049 -.049     
VLDL -.148* -.086 .118 .176* -.042   
Table 4. Correlations between TSH and Lipid Profile parameters in 3rd Trimester (** Correlation is 
significant at the 0.01 level, * Correlation is significant at the 0.05 level) 
 
Discussion 
In second trimester mean TSH level was 1.53mIU/L with standard 
deviation of 1.147mIU/L. In third trimester, the mean TSH level 
was increased to 2.60mIU/L with a standard deviation of 
0.836mIU/L. The t-stat value was found to be -10.649 (p < 0.001), 
which indicates a significant increase in the serum TSH level in 
third trimester as compared to second trimester. 
In our study a correlations between TSH and Lipid Profile 
parameters in 2nd and 3rd trimester was made and we found 
during second trimester, there is significant positive correlation 
between VLDL and HDL (r=0.158, p < 0.05). 
In third trimester TSH was correlated with Cholesterol (r= -0.214, 
p < 0.01) and VLDL (r= -0.148, p < 0.05). This indicates that the TSH 
and Cholesterol & VLDL are negatively associated. When TSH level 
increases, cholesterol levels decreases. Also we observed a 
positive correlation between HDL & Triglyceride (r=0.160, p <0.05) 
and VLDL & HDL (r=0.176, p < 0.05). 
In a study done by Ibrahem et. al., they found that in the second 
trimester a significant positive correlation coefficient existed 
between T3 with triglyceride, VLDL and CHO/HDL. There was a 
negative correlation coefficient between TSH and triglyceride, 
VLDL and T3. In third trimester, there was a negative correlation 
coefficient between T4 with triglyceride and VLDL [25].  
Biondi and Klein reported increase in means TSH levels overall in 
pregnancy [15]. While few other studies have exactly opposite 
[26,27]. Previous studies have shown that TSH is significantly 
associated with lipid profile in the euthyroid population, 
regardless of gender [18]. The influence of TSH on lipid profile has 
been assumed to be mediated indirectly, through its effect on 
thyroid hormones. Furthermore, additional evidence indicates 
that this association is partially contributed by the direct extra-
thyroidal effect of TSH on lipid profile [20]. However, non-
significant positive association between TC and TSH, TG and TSH 
observed among pregnant women may support the assumption 
that TSH directly affects lipid metabolism [19]. 
Circulatory FT3 levels are inversely influenced by TSH, 
consequently the negative relationship with TG among pregnant 
women could also be attributed to low TSH level and the 
stimulation of lipid metabolism by FT3. Hyperthyroidism is 
implicated in hepatic endogenous glucose efflux which triggers 
lipogenesis [28,29]. 
TSH level was found to be associated with gestational age in a 
study. This may be a physiological role of TSH to maintain FT3 level 
to regulate TG synthesis with respect to gestational age [30]. 
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Conclusion 
 
TSH levels rises according to the gestational age, being higher in 
third trimester as compared to second trimester. There is a 
significant negative correlation between TSH levels and 
cholesterol & VLDL in third trimester of the pregnancy. However, 
the levels are still within the normal range. Hence, TSH levels 
should be looked for, especially in third trimester, in order to keep 
the thyroid related problems in check. 
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